Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Bullboard (TSX:LABS)

View:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by Solid1on Jul 03, 2024 3:37am

RE:CEO couldn't issue a press release on

Do you already know what an MD&A report is? 
0
Discussion
Post by pidukson Jul 02, 2024 9:13pm

CEO couldn't issue a press release on

closing of Canna Farms along with an explanation of why and what they are doing?    Shareholders have to read it on a message board or from 'another forum'.    Need any ...more  
62
Discussion
Post by alleyesonmeon Jul 02, 2024 8:59pm

Contributions from another/forum

https://stratcann.com/news/medipharm-to-close-canna-farms-facility-move-medical-sales-to-ontario/
51
Comment by subaru1on Jul 02, 2024 4:58pm

RE:It's all "Top Secret" for 'competitive reasons'?

Iam totally with you, on the CC they mention that MPL worth $0,15 if so they should tell us why we are sitting at $0,075 and what are they going to do to move it at $0,15, this will not happen by ...more  
50
Discussion
Post by pidukson Jul 02, 2024 4:41pm

It's all "Top Secret" for 'competitive reasons'?

There's no filings at the FDA, there's no details of anything, there's no timing of anything, there's no names provided of any 'clients', 'partners', 'customers' ...more  
63
Discussion
Comment by Solid1on Jul 02, 2024 3:51pm

RE:RE:RE:RE:RE:NDA/ANDA/505

What exactly can you find at ....? Medipharm supplies the APIs or gets exclusive production and distribution licenses who knows... I know you'll just keep spamming 
25
Discussion
Comment by QContinuum1on Jul 02, 2024 3:49pm

RE:RE:RE:RE:RE:RE:NDA/ANDA/505

You mean the currently active Phase II trial?  This is no where near ready for prime time.
14
Discussion
Comment by QContinuum1on Jul 02, 2024 3:45pm

RE:RE:RE:RE:NDA/ANDA/505

The acronym NDA certainly is mentioned in the last quarterly report, however as I've stated before as well, there is a big difference between a NDA and an 'investigational' NDA.  The ...more  
22
Discussion
Comment by Solid1on Jul 02, 2024 3:42pm

RE:RE:RE:RE:RE:NDA/ANDA/505

https://www.globenewswire.com/news-release/2019/05/22/1840842/0/en/New-York-City-Ichan-School-of-Medicine-at-Mount-Sinai-and-Renowned-Global-Researcher-Dr-Hurd-Select-MediPharm-Labs-to-Support-500 ...more  
21
Discussion
Comment by Solid1on Jul 02, 2024 3:41pm

RE:RE:RE:RE:NDA/ANDA/505

Not to forget the current study by Dr. Yasmin Hurd with a direct link to Medipharm - the results are also expected this year    https://clinicaltrials.gov/study/NCT06206291?cond=Opiate ...more  
14
Discussion
Comment by Solid1on Jul 02, 2024 3:32pm

RE:RE:RE:NDA/ANDA/505

The ANDA will be approved for a new therapy, and the NDA has already been mentioned several times, most recently in the last quarterly report  
18
Discussion
Comment by QContinuum1on Jul 02, 2024 3:04pm

RE:RE:NDA/ANDA/505

ANDA is Epiodiolex, we know that.  NDA is not and has not been mentioned.
19
Discussion
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities